Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

Clinical trial NCT02008357 · COMPLETED

Trial details

NCT number: NCT02008357
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cognition Disorders

Start date: 2014-02-28
Primary completion: 2022-12-27
Enrollment: 1169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.